PHARMACEUTICAL PRODUCTS CELL THERAPY

Brand Owner (click to sort) Address Description
MATOKO REPLAY HOLDINGS, INC. 5555 OBERLIN DRIVE, SUITE 120 SAN DIEGO CA 92121 pharmaceutical products for cell therapy; cell therapy products;: scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;
SYENA Syena Inc. 5555 Oberlin Drive, Suite 120 San Diego CA 92121 pharmaceutical products for cell therapy; cell therapy products;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;
SYNHLA REPLAY HOLDINGS, INC. 5555 OBERLIN DRIVE, SUITE 120 SAN DIEGO CA 92121 pharmaceutical products for cell therapy; cell therapy products;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;
UCELL REPLAY HOLDINGS, INC. 5555 OBERLIN DRIVE, SUITE 120 SAN DIEGO CA 92121 pharmaceutical products for cell therapy; cell therapy products;U CELL; YOU CELL;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention concerns a method for the determination of apoptotic products in samples taken from patients in which apoptosis is induced as a result of disease or therapy, which is characterized in that the concentration of the apoptotic products in samples taken from patients is correlated with the effectiveness of the therapy and thus serves as a follow-up for the therapy. The serum samples are taken at various times and determined. The present invention in particular concerns a method in which the concentration of nucleosomes is determined in serum samples of tumour patients in order to assess the effectiveness of tumour therapy. Furthermore the present invention also concerns the use of a method according to the invention to determine the effectiveness of therapy in tumour patients who are subjected to a radiotherapy or chemotherapy treatment as well as in patients after an acute ischaemic event or after hypothermia treatment.